Cerevast has a deep portfolio of clinical and development stage programs to improve patient care across the heath care continuum.
Clinical Stage Programs
- Transcranial ultrasound plus tissue plasminogen activator for the treatment of ischemic stroke
(Open IDE, Phase 3) - Ophthalmic ultrasound plus microspheres for the treatment of retinal vein occlusions
(Open IDE, Phase 2)
Development Stage Programs
- Transcranial ultrasound for neuromodulation and post-stroke recovery
- Ultrasound plus microspheres for enhanced drug delivery
Refer to the August 2020 IEEE review article for an independent overview of many of therapeutic applications that Cerevast is pursuing.
